According to previous research [19, 22], ANRIL could epigenetically regulate p15INK4B and p16INK4A in Cis by binding to PRC2, we examined whether ANRIL could regulate p15INK4B and p16INK4A in gastric cancer cells. The gene discussed is CDKN2A; the disease is gastric cancer.